M. Fernet

发表

Poly(ADP-ribose) polymerase (PARP-1) is not involved in DNA double-strand break recovery

V. Favaudon, G. Noël, N. Giocanti, 2003, BMC Cell Biology.

Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis

C. Godon, V. Favaudon, G. Noël, 2006, Molecular Cancer Therapeutics.

Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity.

Janet E. Hall, V. Favaudon, M. Fernet, 2010, DNA repair.

The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations.

P. Hainaut, V. Marcel, L. Tartier, 2009, Biochemical Society transactions.

Variation in radiation-induced apoptosis in ataxia telangiectasia lymphoblastoid cell lines

T. Dörk, J. Hall, M. Fernet, 2003, International journal of radiation biology.

The impact of cyclin-dependent kinase 5 depletion on poly(ADP-ribose) polymerase activity and responses to radiation

D. Biard, L. Vaslin, V. Favaudon, 2011, Cellular and Molecular Life Sciences.

Protection of Endogenous Vitamin E and Beta-Carotene by Aminoguanidine upon Oxidation of Human Low-Density Lipoproteins by ·OH/O2·−

D. Bonnefont-Rousselot, M. Fernet, D. Jore, 2000, Radiation research.

Hyperfast, early cell response to ionizing radiation.

E. Deniaud-Alexandre, V. Favaudon, N. Giocanti, 2000, International journal of radiation biology.

PARP-2 depletion results in lower radiation cell survival but cell line-specific differences in poly(ADP-ribose) levels

D. Biard, V. Favaudon, F. Cordelières, 2015, Cellular and Molecular Life Sciences.

The impact of cyclin-dependent kinase 5 depletion on poly(ADP-ribose) polymerase activity and responses to radiation

D. Biard, V. Favaudon, F. Cordelières, 2011, Cellular and Molecular Life Sciences.

The methyl methanesulfonate induced S-phase delay in XRCC1-deficient cells requires ATM and ATR.

M. Fernet, B. Chapot, R. Brem, 2008, DNA repair.

Isolated generalized dystonia in biallelic missense mutations of the ATM gene

W. Meissner, D. Stoppa-Lyonnet, F. Tison, 2013, Movement disorders : official journal of the Movement Disorder Society.

Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.

M. Koenig, M. Gribaa, M. Fernet, 2005, Human molecular genetics.

Functional consequences of ATM sequence variants for chromosomal radiosensitivity

T. Dörk, M. Bremer, D. Stoppa-Lyonnet, 2004, Genes, chromosomes & cancer.

Mutation in TTI2 Reveals a Role for Triple T Complex in Human Brain Development

A. Munnich, M. Stern, P. Nitschké, 2013, Human mutation.

Predictive markers for normal tissue reactions: fantasy or reality?

M. Fernet, J. Hall, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

A role for PKCζ in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin

E. Solary, C. Hennequin, V. Favaudon, 2005, Molecular Cancer Therapeutics.

Cancer Biomarkers Associated with Damage Response Genes

A. Kiltie, M. Fernet, Janet Hall, 2009 .

The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage

W. Reith, S. Mandriota, F. Gumy-Pause, 2012, Oncogenesis.

Genetic biomarkers of therapeutic radiation sensitivity.

M. Fernet, Janet Hall, 2004, DNA repair.

Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients

S. Vacher, I. Bièche, D. Biard, 2015, Cell cycle.

Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers

D. Stoppa-Lyonnet, J. Hall, N. Moullan, 2004, British Journal of Cancer.

EPI-CT: in vitro assessment of the applicability of the γ-H2AX-foci assay as cellular biomarker for exposure in a multicentre study of children in diagnostic radiology

H. Thierens, S. Baatout, D. Samaga, 2015, International journal of radiation biology.

PARP-2 depletion results in lower radiation cell survival but cell line-specific differences in poly(ADP-ribose) levels

D. Biard, V. Favaudon, F. Cordelières, 2014, Cellular and Molecular Life Sciences.

Phenotypic cellular characterization of an Ataxia telangiectasia patient carrying a causal homozygous missense mutation

D. Stoppa-Lyonnet, J. Couturier, N. Moullan, 2003, Human mutation.

Re: correspondence from Dr. Michael Swift, Disease Insight Research Foundation, concerning Gutiérrez‐Enríquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa‐Lyonnet D, Moullan N, Angèle S, Hall J, “Functional consequences of the ATM sequence variants for chromosomal radiosensitivity”

T. Dörk, D. Stoppa-Lyonnet, S. Gutiérrez‐Enríquez, 2005 .

Poly(ADP-ribose) polymerase, a major determinant of early cell response to ionizing radiation.

J. Ménissier-de murcia, G. de Murcia, E. Deniaud-Alexandre, 2000, International journal of radiation biology.

Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status

A. Larsen, V. Favaudon, N. Giocanti, 2016, Targeted Oncology.

Poly(ADP-ribose) polymerase (PARP-1) is not involved in DNA double-strand break recovery

V. Favaudon, N. Giocanti, M. Fernet, 2003 .

13C-NMR studies of glucose metabolism in osmolarity mutants of Saccharomyces cerevisiae

M. Gustin, J. Shanks, M. Fernet, 1994 .

Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis

C. Godon, V. Favaudon, G. Noël, 2006, Molecular Cancer Therapeutics.